Login / Signup

Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines.

Jonas M den HeijerJules A A C HeubergerHemme HijmaAnnelieke C KruithofJeroen van SmedenGeert Jan GroeneveldJacobus BurggraafAdam A Cohen
Published in: British journal of clinical pharmacology (2021)
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial